Utilizing the Superior Antibody-Dependent Cellular Cytotoxicity, Effector Functions, & Improved Persistence of g-NK Cells When Compared to Conventional NK cells

Time: 10:00 am
day: Innate Immune Checkpoints & Activation Pre-Focus Day


  • Discussing the enhanced in vivo efficacy and persistence of g-NK cells and the ability of g-NK cells to induce regression of established tumors leading to durable elimination of tumor burden
  • Elucidating the unique feature of g-NK cells which enable the development of an off-the-shelf cancer immunotherapy combined with therapeutic IgG antibodies
  • Combining g-NK cells with anti-CD38 antibodies for the treatment of multiple myeloma without the need for genetic engineering